Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study
•We proposed a novel treatment scheme of lipiodol-microsphere mixed transarterial chemoembolization (mTACE) combined with microwave ablation (MWA) for colorectal liver metastases (CRLM) in this study.•Patients with CRLM who underwent MWA-mTACE had better local tumor control and improved progression-...
Gespeichert in:
| Veröffentlicht in: | Clinics and research in hepatology and gastroenterology 2022-08, Vol.46 (7), p.101986-101986, Article 101986 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 101986 |
|---|---|
| container_issue | 7 |
| container_start_page | 101986 |
| container_title | Clinics and research in hepatology and gastroenterology |
| container_volume | 46 |
| creator | Shi, Qin Wang, Feihang Du, Nan Zhou, Yongjie Zhou, Xin Ma, Jingqin Yang, Minjie Zhang, Zihan Yu, Jiaze Zhang, Wen Luo, Jianjun Liu, Lingxiao Yan, Zhiping |
| description | •We proposed a novel treatment scheme of lipiodol-microsphere mixed transarterial chemoembolization (mTACE) combined with microwave ablation (MWA) for colorectal liver metastases (CRLM) in this study.•Patients with CRLM who underwent MWA-mTACE had better local tumor control and improved progression-free survival than those who underwent MWA-cTACE.•Univariate and multivariate analyses indicated that, MWA-mTACE was an independent positive factor for progression-free survival, and abnormal carcinoembryonic antigen level was a hazard factor for overall survival.•mTACE combined with MWA might be a hopeful combination therapy for patients with CRLM.
To investigate the clinical outcomes of microwave ablation (MWA) combined with lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional TACE (cTACE) for patients with colorectal liver metastases (CRLM).
This retrospective study evaluated the medical records of patients with CRLM who underwent MWA combined with mTACE or cTACE from January 2018 to September 2021. The objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS) and overall survival (OS) were evaluated during the follow-up. In addition, prognostic factors affecting survival were analyzed by univariate and multivariate methods.
A total of 79 patients with CRLM were enrolled in the study (MWA-mTACE group, n = 38; MWA-cTACE group, n = 41). The patients who underwent MWA-mTACE had higher DCR (86.8% vs. 65.9%, P = 0.029) and better PFS (median, 8.1 vs. 5.5 months, P = 0.018) than those who underwent MWA-cTACE, but no significant difference was found in ORR (34.2% vs. 22.0%, P = 0.225) and OS (median, 15.7 vs. 13.0 months, P = 0.231). Further univariate and multivariate analyses indicated that MWA-mTACE was an independent positive factor for PFS, and abnormal carcinoembryonic antigen level was a hazard factor for OS. The postoperative laboratory tests and complications in patients who underwent MWA-mTACE were similar to those who underwent MWA-cTACE.
Lipiodol-microsphere mixed TACE might be an effective and safe treatment to combine with microwave ablation for patients with colorectal liver metastases. |
| doi_str_mv | 10.1016/j.clinre.2022.101986 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2684102296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2210740122001206</els_id><sourcerecordid>2684102296</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-f8e9fd16d312ba9a19fca68fd1b805544d5636341523f5eb84cced8833d2061e3</originalsourceid><addsrcrecordid>eNp9kdFuFCEUhonR2Kb2DYzh0ptZgZlhGS9MmkZbkxpvNPGOMHAmywaGFdit9bV8Qc9kai8lJMDh-8-B8xPymrMNZ1y-229s8HOGjWBCLKFByWfkXAjOmm3Hfzx_2jN-Ri5L2TMcXc_Ulr8kZ22_3QqpunPy54u3Od2bE1AzBlN9mqlNcfQzOHrv644Gf_DJpdDEhSyHHWSg0f_C-5SRnU8wLzITaM1mLiZXyB5PdgcxQRxT8L_XxBMK6g6QA1MjymiaMENIGWxFRfAnyDRCNQUnlPf0imaoS1UE8JKWenQPr8iLyYQCl4_rBfn-6eO369vm7uvN5-uru8a2UtRmUjBMjkvXcjGawfBhskYqDI2K9X3XuV62su14L9qph1F11oJTqm2dYJJDe0HernkPOf08Qqk6-mIhBDNDOha9dJBj_weJaLeiS4tKhkkfso8mP2jO9OKY3uvVMb04plfHUPbmscJxjOCeRP_8QeDDCgD-8-Qh62I9zPhOv_RMu-T_X-Ev6pSvJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2684102296</pqid></control><display><type>article</type><title>Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shi, Qin ; Wang, Feihang ; Du, Nan ; Zhou, Yongjie ; Zhou, Xin ; Ma, Jingqin ; Yang, Minjie ; Zhang, Zihan ; Yu, Jiaze ; Zhang, Wen ; Luo, Jianjun ; Liu, Lingxiao ; Yan, Zhiping</creator><creatorcontrib>Shi, Qin ; Wang, Feihang ; Du, Nan ; Zhou, Yongjie ; Zhou, Xin ; Ma, Jingqin ; Yang, Minjie ; Zhang, Zihan ; Yu, Jiaze ; Zhang, Wen ; Luo, Jianjun ; Liu, Lingxiao ; Yan, Zhiping</creatorcontrib><description>•We proposed a novel treatment scheme of lipiodol-microsphere mixed transarterial chemoembolization (mTACE) combined with microwave ablation (MWA) for colorectal liver metastases (CRLM) in this study.•Patients with CRLM who underwent MWA-mTACE had better local tumor control and improved progression-free survival than those who underwent MWA-cTACE.•Univariate and multivariate analyses indicated that, MWA-mTACE was an independent positive factor for progression-free survival, and abnormal carcinoembryonic antigen level was a hazard factor for overall survival.•mTACE combined with MWA might be a hopeful combination therapy for patients with CRLM.
To investigate the clinical outcomes of microwave ablation (MWA) combined with lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional TACE (cTACE) for patients with colorectal liver metastases (CRLM).
This retrospective study evaluated the medical records of patients with CRLM who underwent MWA combined with mTACE or cTACE from January 2018 to September 2021. The objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS) and overall survival (OS) were evaluated during the follow-up. In addition, prognostic factors affecting survival were analyzed by univariate and multivariate methods.
A total of 79 patients with CRLM were enrolled in the study (MWA-mTACE group, n = 38; MWA-cTACE group, n = 41). The patients who underwent MWA-mTACE had higher DCR (86.8% vs. 65.9%, P = 0.029) and better PFS (median, 8.1 vs. 5.5 months, P = 0.018) than those who underwent MWA-cTACE, but no significant difference was found in ORR (34.2% vs. 22.0%, P = 0.225) and OS (median, 15.7 vs. 13.0 months, P = 0.231). Further univariate and multivariate analyses indicated that MWA-mTACE was an independent positive factor for PFS, and abnormal carcinoembryonic antigen level was a hazard factor for OS. The postoperative laboratory tests and complications in patients who underwent MWA-mTACE were similar to those who underwent MWA-cTACE.
Lipiodol-microsphere mixed TACE might be an effective and safe treatment to combine with microwave ablation for patients with colorectal liver metastases.</description><identifier>ISSN: 2210-7401</identifier><identifier>EISSN: 2210-741X</identifier><identifier>DOI: 10.1016/j.clinre.2022.101986</identifier><identifier>PMID: 35772684</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Carcinoma, Hepatocellular - pathology ; Chemoembolization, Therapeutic - methods ; Colorectal liver metastases ; Colorectal Neoplasms - therapy ; Ethiodized Oil ; Humans ; Lipiodol-microsphere mixed transarterial chemoembolization ; Liver Neoplasms - pathology ; Microspheres ; Microwave ablation ; Microwaves - therapeutic use ; Retrospective Studies ; Survival ; Treatment Outcome</subject><ispartof>Clinics and research in hepatology and gastroenterology, 2022-08, Vol.46 (7), p.101986-101986, Article 101986</ispartof><rights>2022 Elsevier Masson SAS</rights><rights>Copyright © 2022 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-f8e9fd16d312ba9a19fca68fd1b805544d5636341523f5eb84cced8833d2061e3</citedby><cites>FETCH-LOGICAL-c362t-f8e9fd16d312ba9a19fca68fd1b805544d5636341523f5eb84cced8833d2061e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2210740122001206$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35772684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shi, Qin</creatorcontrib><creatorcontrib>Wang, Feihang</creatorcontrib><creatorcontrib>Du, Nan</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Zhou, Xin</creatorcontrib><creatorcontrib>Ma, Jingqin</creatorcontrib><creatorcontrib>Yang, Minjie</creatorcontrib><creatorcontrib>Zhang, Zihan</creatorcontrib><creatorcontrib>Yu, Jiaze</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Luo, Jianjun</creatorcontrib><creatorcontrib>Liu, Lingxiao</creatorcontrib><creatorcontrib>Yan, Zhiping</creatorcontrib><title>Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study</title><title>Clinics and research in hepatology and gastroenterology</title><addtitle>Clin Res Hepatol Gastroenterol</addtitle><description>•We proposed a novel treatment scheme of lipiodol-microsphere mixed transarterial chemoembolization (mTACE) combined with microwave ablation (MWA) for colorectal liver metastases (CRLM) in this study.•Patients with CRLM who underwent MWA-mTACE had better local tumor control and improved progression-free survival than those who underwent MWA-cTACE.•Univariate and multivariate analyses indicated that, MWA-mTACE was an independent positive factor for progression-free survival, and abnormal carcinoembryonic antigen level was a hazard factor for overall survival.•mTACE combined with MWA might be a hopeful combination therapy for patients with CRLM.
To investigate the clinical outcomes of microwave ablation (MWA) combined with lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional TACE (cTACE) for patients with colorectal liver metastases (CRLM).
This retrospective study evaluated the medical records of patients with CRLM who underwent MWA combined with mTACE or cTACE from January 2018 to September 2021. The objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS) and overall survival (OS) were evaluated during the follow-up. In addition, prognostic factors affecting survival were analyzed by univariate and multivariate methods.
A total of 79 patients with CRLM were enrolled in the study (MWA-mTACE group, n = 38; MWA-cTACE group, n = 41). The patients who underwent MWA-mTACE had higher DCR (86.8% vs. 65.9%, P = 0.029) and better PFS (median, 8.1 vs. 5.5 months, P = 0.018) than those who underwent MWA-cTACE, but no significant difference was found in ORR (34.2% vs. 22.0%, P = 0.225) and OS (median, 15.7 vs. 13.0 months, P = 0.231). Further univariate and multivariate analyses indicated that MWA-mTACE was an independent positive factor for PFS, and abnormal carcinoembryonic antigen level was a hazard factor for OS. The postoperative laboratory tests and complications in patients who underwent MWA-mTACE were similar to those who underwent MWA-cTACE.
Lipiodol-microsphere mixed TACE might be an effective and safe treatment to combine with microwave ablation for patients with colorectal liver metastases.</description><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Chemoembolization, Therapeutic - methods</subject><subject>Colorectal liver metastases</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Ethiodized Oil</subject><subject>Humans</subject><subject>Lipiodol-microsphere mixed transarterial chemoembolization</subject><subject>Liver Neoplasms - pathology</subject><subject>Microspheres</subject><subject>Microwave ablation</subject><subject>Microwaves - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Survival</subject><subject>Treatment Outcome</subject><issn>2210-7401</issn><issn>2210-741X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kdFuFCEUhonR2Kb2DYzh0ptZgZlhGS9MmkZbkxpvNPGOMHAmywaGFdit9bV8Qc9kai8lJMDh-8-B8xPymrMNZ1y-229s8HOGjWBCLKFByWfkXAjOmm3Hfzx_2jN-Ri5L2TMcXc_Ulr8kZ22_3QqpunPy54u3Od2bE1AzBlN9mqlNcfQzOHrv644Gf_DJpdDEhSyHHWSg0f_C-5SRnU8wLzITaM1mLiZXyB5PdgcxQRxT8L_XxBMK6g6QA1MjymiaMENIGWxFRfAnyDRCNQUnlPf0imaoS1UE8JKWenQPr8iLyYQCl4_rBfn-6eO369vm7uvN5-uru8a2UtRmUjBMjkvXcjGawfBhskYqDI2K9X3XuV62su14L9qph1F11oJTqm2dYJJDe0HernkPOf08Qqk6-mIhBDNDOha9dJBj_weJaLeiS4tKhkkfso8mP2jO9OKY3uvVMb04plfHUPbmscJxjOCeRP_8QeDDCgD-8-Qh62I9zPhOv_RMu-T_X-Ev6pSvJw</recordid><startdate>202208</startdate><enddate>202208</enddate><creator>Shi, Qin</creator><creator>Wang, Feihang</creator><creator>Du, Nan</creator><creator>Zhou, Yongjie</creator><creator>Zhou, Xin</creator><creator>Ma, Jingqin</creator><creator>Yang, Minjie</creator><creator>Zhang, Zihan</creator><creator>Yu, Jiaze</creator><creator>Zhang, Wen</creator><creator>Luo, Jianjun</creator><creator>Liu, Lingxiao</creator><creator>Yan, Zhiping</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202208</creationdate><title>Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study</title><author>Shi, Qin ; Wang, Feihang ; Du, Nan ; Zhou, Yongjie ; Zhou, Xin ; Ma, Jingqin ; Yang, Minjie ; Zhang, Zihan ; Yu, Jiaze ; Zhang, Wen ; Luo, Jianjun ; Liu, Lingxiao ; Yan, Zhiping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-f8e9fd16d312ba9a19fca68fd1b805544d5636341523f5eb84cced8833d2061e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Chemoembolization, Therapeutic - methods</topic><topic>Colorectal liver metastases</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Ethiodized Oil</topic><topic>Humans</topic><topic>Lipiodol-microsphere mixed transarterial chemoembolization</topic><topic>Liver Neoplasms - pathology</topic><topic>Microspheres</topic><topic>Microwave ablation</topic><topic>Microwaves - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Survival</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shi, Qin</creatorcontrib><creatorcontrib>Wang, Feihang</creatorcontrib><creatorcontrib>Du, Nan</creatorcontrib><creatorcontrib>Zhou, Yongjie</creatorcontrib><creatorcontrib>Zhou, Xin</creatorcontrib><creatorcontrib>Ma, Jingqin</creatorcontrib><creatorcontrib>Yang, Minjie</creatorcontrib><creatorcontrib>Zhang, Zihan</creatorcontrib><creatorcontrib>Yu, Jiaze</creatorcontrib><creatorcontrib>Zhang, Wen</creatorcontrib><creatorcontrib>Luo, Jianjun</creatorcontrib><creatorcontrib>Liu, Lingxiao</creatorcontrib><creatorcontrib>Yan, Zhiping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinics and research in hepatology and gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shi, Qin</au><au>Wang, Feihang</au><au>Du, Nan</au><au>Zhou, Yongjie</au><au>Zhou, Xin</au><au>Ma, Jingqin</au><au>Yang, Minjie</au><au>Zhang, Zihan</au><au>Yu, Jiaze</au><au>Zhang, Wen</au><au>Luo, Jianjun</au><au>Liu, Lingxiao</au><au>Yan, Zhiping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study</atitle><jtitle>Clinics and research in hepatology and gastroenterology</jtitle><addtitle>Clin Res Hepatol Gastroenterol</addtitle><date>2022-08</date><risdate>2022</risdate><volume>46</volume><issue>7</issue><spage>101986</spage><epage>101986</epage><pages>101986-101986</pages><artnum>101986</artnum><issn>2210-7401</issn><eissn>2210-741X</eissn><abstract>•We proposed a novel treatment scheme of lipiodol-microsphere mixed transarterial chemoembolization (mTACE) combined with microwave ablation (MWA) for colorectal liver metastases (CRLM) in this study.•Patients with CRLM who underwent MWA-mTACE had better local tumor control and improved progression-free survival than those who underwent MWA-cTACE.•Univariate and multivariate analyses indicated that, MWA-mTACE was an independent positive factor for progression-free survival, and abnormal carcinoembryonic antigen level was a hazard factor for overall survival.•mTACE combined with MWA might be a hopeful combination therapy for patients with CRLM.
To investigate the clinical outcomes of microwave ablation (MWA) combined with lipiodol-microsphere mixed transarterial chemoembolization (mTACE) or conventional TACE (cTACE) for patients with colorectal liver metastases (CRLM).
This retrospective study evaluated the medical records of patients with CRLM who underwent MWA combined with mTACE or cTACE from January 2018 to September 2021. The objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS) and overall survival (OS) were evaluated during the follow-up. In addition, prognostic factors affecting survival were analyzed by univariate and multivariate methods.
A total of 79 patients with CRLM were enrolled in the study (MWA-mTACE group, n = 38; MWA-cTACE group, n = 41). The patients who underwent MWA-mTACE had higher DCR (86.8% vs. 65.9%, P = 0.029) and better PFS (median, 8.1 vs. 5.5 months, P = 0.018) than those who underwent MWA-cTACE, but no significant difference was found in ORR (34.2% vs. 22.0%, P = 0.225) and OS (median, 15.7 vs. 13.0 months, P = 0.231). Further univariate and multivariate analyses indicated that MWA-mTACE was an independent positive factor for PFS, and abnormal carcinoembryonic antigen level was a hazard factor for OS. The postoperative laboratory tests and complications in patients who underwent MWA-mTACE were similar to those who underwent MWA-cTACE.
Lipiodol-microsphere mixed TACE might be an effective and safe treatment to combine with microwave ablation for patients with colorectal liver metastases.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>35772684</pmid><doi>10.1016/j.clinre.2022.101986</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2210-7401 |
| ispartof | Clinics and research in hepatology and gastroenterology, 2022-08, Vol.46 (7), p.101986-101986, Article 101986 |
| issn | 2210-7401 2210-741X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2684102296 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Carcinoma, Hepatocellular - pathology Chemoembolization, Therapeutic - methods Colorectal liver metastases Colorectal Neoplasms - therapy Ethiodized Oil Humans Lipiodol-microsphere mixed transarterial chemoembolization Liver Neoplasms - pathology Microspheres Microwave ablation Microwaves - therapeutic use Retrospective Studies Survival Treatment Outcome |
| title | Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A41%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microwave%20ablation%20combined%20with%20lipiodol-microsphere%20mixed%20or%20conventional%20transarterial%20chemoembolization%20for%20the%20treatment%20of%20colorectal%20liver%20metastases:%20A%20retrospective%20study&rft.jtitle=Clinics%20and%20research%20in%20hepatology%20and%20gastroenterology&rft.au=Shi,%20Qin&rft.date=2022-08&rft.volume=46&rft.issue=7&rft.spage=101986&rft.epage=101986&rft.pages=101986-101986&rft.artnum=101986&rft.issn=2210-7401&rft.eissn=2210-741X&rft_id=info:doi/10.1016/j.clinre.2022.101986&rft_dat=%3Cproquest_cross%3E2684102296%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2684102296&rft_id=info:pmid/35772684&rft_els_id=S2210740122001206&rfr_iscdi=true |